Citation tools
"Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (Ormdl3) Expression and Normalizes Ceramide Imbalance." Journal of Pharmacology and Experimental Therapeutics
373.3
(2020):
476-487.
Web. 19 Mar. 2024.